HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid

HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid

On the occasion of National Bioproduction and Biomedicines Day (JNBB), which enjoys the high patronage of the President of the French Republic, HTL Biotechnology confirms its position as  a global leader in the development and  production of pharmaceutical-grade biopolymers, by inaugurating a new production unit dedicated to sterile hyaluronic acid at its Javené (Ille-et-Vilaine) site, a true flagship of French biomanufacturing. 

Press Release